AN2 Therapeutics, Inc. Profile Avatar - Palmy Investing

AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous …

Biotechnology
US, Menlo Park [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of ANTX's Analysis
CIK: 1880438 CUSIP: 037326105 ISIN: US0373261058 LEI: - UEI: -
Secondary Listings
ANTX has no secondary listings inside our databases.